HTG Molecular Diagnostics Reports First Quarter 2022 Results
May 12, 2022 16:01 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., May 12, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics to Announce Q1 2022 Financial Results and Host Conference Call on Thursday, May 12
May 05, 2022 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., May 05, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Expands Therapeutics Team
April 13, 2022 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., April 13, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Expands Features of Proprietary HTG EdgeSeq Technology
April 06, 2022 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., April 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Releases Proof-of-Approach Whitepaper Establishing Utility of Transcriptome-Informed Approach to Drug Discovery
March 31, 2022 16:50 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., March 31, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics Reports Full Year 2021 Results
March 29, 2022 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., March 29, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics to Announce Year End 2021 Financial Results and Host Conference Call on Tuesday, March 29
March 22, 2022 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., March 22, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Molecular Diagnostics Announces $7.5 Million Private Placement
March 18, 2022 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., March 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it...
HTG Names Renowned RNA Expert Dr. Robert Spitale to Therapeutics Scientific Advisory Board
February 03, 2022 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Feb. 03, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors
January 28, 2022 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Jan. 28, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...